Spain | Country Update

News And Analysis

Innovator and generics drug companies share their reaction to the judgment in Warner-Lambert v Generics. One in-house lawyer explains that it will be particularly detrimental to small innovator companies and “does not reflect the scientific reality of drug development”

Technology, life sciences and manufacturing companies say they’re increasingly bringing patent processes in house to make them more cost efficient. The challenge is working out when a function is better done internally, outsourced to private practice or split between the two

For this edition of the Women in IP Interview, Lucy Songi speaks to Imogen Fowler (Hogan Lovells), Mireille Buydens (Janson Baugniet) and Ellen Shankman (Ellen B Shankman & Associates) about their experiences and what advice they would offer to up-and-coming IP practitioners

Research for the 2017 edition of IP Stars, Managing IP’s legal directory, starts today. Kingsley Egbuonu and Jennifer Ruther highlight some of the things you need to know and why IP firms and practitioners worldwide should participate by making a submission

In the latest in our series of UPC scenarios, Laura Whiting and Inmaculada Lorenzo explore the options for a pharmaceutical patent owner faced with a potential infringer manufacturing its product in Spain